Co-Phenylcaine for Epistaxis
Co-phenylcaine (lidocaine 5% with phenylephrine 0.5%) should be applied topically via spray or cotton pledgets to provide both anesthesia and vasoconstriction for anterior epistaxis, particularly as preparation for nasal cautery, which is the definitive treatment when a bleeding site is visible. 1
Application Method and Dosage
Apply co-phenylcaine using one of two techniques:
- Direct spray application: 2-5 puffs per nostril 2, 3
- Cotton pledgets or patties: Soak pledgets with the solution and place directly into the nasal cavity for 10 minutes 4, 5
The combination provides dual benefit: lidocaine delivers local anesthesia while phenylephrine (0.5% concentration) causes vasoconstriction of nasal mucosa 4, 2. This preparation is essential before proceeding to definitive cautery treatment.
Role in Epistaxis Management Algorithm
Co-phenylcaine serves as an adjunctive agent, not primary treatment. The proper sequence is:
- First-line: Direct nasal compression for 15 minutes 6
- If bleeding persists: Apply co-phenylcaine for anesthesia and vasoconstriction
- Definitive treatment: Cauterize the visible bleeding site (preferably with bipolar electrocautery) 1
The 2020 American Academy of Otolaryngology guidelines explicitly recommend lidocaine with a topical decongestant for anesthesia prior to cautery, noting that cautery is more effective than packing when a bleeding site can be identified 1. Cautery should only be performed when an anterior bleeding site is clearly visible 1.
Critical Contraindications
Exercise extreme caution or avoid co-phenylcaine in patients with:
- Uncontrolled epilepsy (lidocaine contraindication) 1
- Class III antiarrhythmic use (lidocaine interaction) 1
- Heart disease, uncontrolled hypertension, thyroid disease, or diabetes (phenylephrine contraindication) 7
- Concurrent use of MAO inhibitors or antihypertensive medications (phenylephrine interaction) 7
The New York State guidelines on phenylephrine use document severe hypertensive crises (BP up to 250/150 mmHg) and fatal pulmonary edema when phenylephrine was used topically in nasal procedures, particularly when β-blockers were administered to treat the resulting hypertension 8. Never treat phenylephrine-induced hypertension with β-blockers alone—this can precipitate unopposed α-adrenergic stimulation and pulmonary edema 8.
Important Clinical Caveats
Concentration matters critically: The safe concentration is 0.25-0.5% phenylephrine 8, 4. Higher concentrations (1%) have caused severe hypertensive emergencies 8. The co-phenylcaine formulation contains 0.5% phenylephrine, which is within the acceptable range 7, 4.
Measure the dose: Never apply unmeasured amounts. The reported fatalities involved unmeasured instillation of phenylephrine solutions 8.
Monitor blood pressure: Hypertensive responses typically occur within 5-10 minutes of application 8. If severe hypertension develops, increase volatile anesthetic concentration rather than administering β-blockers 8.
Evidence Quality Considerations
While co-phenylcaine is widely used and recommended in guidelines 1, the evidence base shows it functions primarily as an adjunct to facilitate cautery rather than as standalone treatment. A 2025 study found oxymetazoline superior to epinephrine-lidocaine combinations for achieving hemostasis (71% vs 49% success) 6, and topical tranexamic acid showed better outcomes than phenylephrine-lidocaine packing in patients on antiplatelet agents 9. However, these studies evaluated different clinical contexts than co-phenylcaine's primary role as pre-cautery preparation.
The key principle: Co-phenylcaine prepares the nose for the definitive intervention (cautery), rather than serving as the primary hemostatic agent. The 2020 AAO-HNS guidelines emphasize that cautery is more effective than packing when a bleeding site can be identified 1, making proper anesthesia and vasoconstriction with agents like co-phenylcaine essential for successful cautery.
Practical Application
For anterior epistaxis management:
- Apply 2-5 puffs of co-phenylcaine spray per nostril OR insert soaked pledgets
- Wait 10 minutes for full anesthetic and vasoconstrictive effect 5, 2
- Use headlight, nasal speculum, and suction to identify the bleeding site 1
- Cauterize only the visible bleeding site with silver nitrate or electrocautery 1
- Avoid bilateral septal cautery to prevent perforation risk 1